ong-term prognosis follow-up study on prevention and treatment of COVID-19 patients with Traditional Chinese medicine
Not Applicable
Recruiting
- Conditions
- ovel coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2100005478
- Lead Sponsor
- Institute of Basic Clinical Medicine of Chinese Medicine, China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
COVID-19 patients who were hospitalized and discharged alive in the implementation unit between January 2020 and December 2021.
The clinical data during hospitalization were complete
Agree to participate in this study
Exclusion Criteria
patients who refuse to participate in the study
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie TCM's efficacy in preventing and treating COVID-19 in observational studies?
How does Traditional Chinese Medicine compare to standard-of-care treatments in long-term outcomes for SARS-CoV-2 pneumonia patients?
Which biomarkers are associated with favorable prognosis in TCM-treated patients with novel coronavirus pneumonia?
What are the potential adverse events and safety management strategies for TCM interventions in post-COVID-19 recovery?
Are there combination approaches involving TCM and antiviral agents for SARS-CoV-2 that show improved therapeutic outcomes?